Initial Statement of Beneficial Ownership (3)
17 Agosto 2021 - 4:21PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wyzga Michael D |
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/16/2021
|
3. Issuer Name and Ticker or Trading Symbol
YUMANITY THERAPEUTICS, INC. [YMTX]
|
(Last)
(First)
(Middle)
C/O YUMANITY THERAPEUTICS, INC., 40 GUEST STREET, SUITE 4410 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) See Remarks / |
(Street)
BOSTON, MA 02135
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
Remarks: Sr. VP & Chief Financial Officer
Exhibit 24 - Power of Attorney |
No securities are beneficially owned. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Wyzga Michael D C/O YUMANITY THERAPEUTICS, INC. 40 GUEST STREET, SUITE 4410 BOSTON, MA 02135 |
|
| See Remarks |
|
Signatures
|
/s/ Michael Wyzga | | 8/17/2021 |
**Signature of Reporting Person | Date |
Proteostasis Therapeutics (NASDAQ:PTI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Proteostasis Therapeutics (NASDAQ:PTI)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Proteostasis Therapeutics Inc (NASDAQ): 0 recent articles
Más de Yumanity Therapeutics, Inc. Artículos de Noticias